CURLF
Curaleaf Holdings

8,699
Mkt Cap
$2.06B
Volume
141,999.00
52W High
$3.65
52W Low
$0.675
PE Ratio
-7.66
CURLF Fundamentals
Price
$2.68
Prev Close
$2.67
Open
$2.66
50D MA
$2.70
Beta
1.01
Avg. Volume
488,899.16
EPS (Annual)
-$0.3215
P/B
2.51
Loading...
Loading...
News
all
press releases
TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
Zacks·8d ago
News Placeholder
More News
News Placeholder
TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
Zacks·8d ago
News Placeholder
TLRY Stock Loses 38% in a Month: Should You Buy the Dip?
Tilray's slump deepens as a tighter U.S. hemp rule and a reverse split stir uncertainty despite gains in global cannabis sales.
Zacks·8d ago
News Placeholder
Tilray, IIPR, Trulieve, Other Cannabis Stocks Rally On Report Of Government Considering Adding CBD Treatment For Medicare Patients
The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare.
Stocktwits·15d ago
News Placeholder
Cresco Labs Expands Operations Beyond U.S.: How to Play the Stock?
CRLBF's move into Germany opens a new growth path as it navigates U.S. pricing pressure and rising competition in its core market.
Zacks·22d ago
News Placeholder
Should You Buy, Hold or Sell CGC Stock Post Q2 Earnings Release?
Canopy Growth's narrower loss, rising Canadian sales and improving margins signal progress in its turnaround, even as competition and global headwinds persist.
Zacks·28d ago
News Placeholder
Tilray Brands Extends Global Reach With Key Approvals and Launches
TLRY expands its global medical cannabis footprint with key launches and approvals across Panama, Germany, Italy and Australia.
Zacks·1mo ago
News Placeholder
Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?
TLRY's 94.5% surge, record fiscal Q1 revenues, and expanding medical cannabis footprint fuel optimism amid global challenges.
Zacks·1mo ago
News Placeholder
Curaleaf Holdings, Inc. (CURLF) Reports Q3 Loss, Beats Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and +1.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Can TerrAscend Deliver a Solid Q3 on Core Market Strength Ahead?
TSNDF's Q3 results are likely to benefit from Northeast market strength, margin gains, and a streamlined focus following its Michigan exit.
Zacks·1mo ago

Latest CURLF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.